Changeflow GovPing Healthcare & Life Sciences Method and Apparatus for Ablating a Target Volume
Routine Notice Added Final

Method and Apparatus for Ablating a Target Volume

Favicon for changeflow.com USPTO Patent Applications - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO published patent application US20260090837A1 for a method and apparatus supporting ablation of a target volume in medical procedures. The invention describes a control circuit that registers three-dimensional patient imaging with ablation zone information to generate two-dimensional coverage representations. Inventors include Hojjatollah Fallahi, Dane Olson, and Gael Luis Boivin.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This patent application discloses a method and apparatus for ablation treatment planning and visualization. The control circuit accesses three-dimensional image data of a target volume specific to a patient and combines it with ablation zone information corresponding to the treatment context. The system registers this data and generates a two-dimensional representation showing target volume coverage by the ablation zone, presented via a user interface.

Patent applications do not impose compliance obligations on industry. Medical device manufacturers developing ablation systems may review this publication for competitive intelligence purposes. No action is required, as published patent applications do not create deadlines, penalties, or new regulatory requirements.

Archived snapshot

Apr 3, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHOD AND APPARATUS IN SUPPORT OF ABLATING A TARGET VOLUME

Application US20260090837A1 Kind: A1 Apr 02, 2026

Inventors

Hojjatollah Fallahi, Dane Olson, Gael Luis Boivin

Abstract

A control circuit can access three-dimensional image information of a target volume for a particular patient as well as ablation zone information corresponding to a particular ablation treatment context. The control circuit can then register the three-dimensional image information of the target volume with the ablation zone information to generate resultant information, and then generate a two-dimensional representation of target volume coverage by a corresponding ablation zone as a function of the resultant information. That two-dimensional representation of target volume coverage by the corresponding ablation zone can then be presented via a user interface.

CPC Classifications

A61B 34/10 A61B 18/1815 A61B 34/25 A61B 2018/1869 A61B 2034/104 A61B 2034/107

Filing Date

2024-10-02

Application No.

18904182

View original document →

Get daily alerts for USPTO Patent Applications - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260090837A1

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent Applications
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Legal
Topics
Healthcare Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!